AFT Pharmaceuticals partners with Mark Cuban Cost Plus Marketplace to bring the new non-opioid pain medication, Combogesic® to the U.S.

PartnershipCombogesic®Positive

AI Analysis

Summary

AFT Pharmaceuticals announced a U.S. launch partnership with Mark Cuban Cost Plus Marketplace for Combogesic®, a prescription-strength non-opioid pain medication combining acetaminophen and ibuprofen for mild-to-moderate acute pain treatment.

Importance:5/10

Sentiment:

0.60

product launchnon-opioid pain medicationpartnershipU.S. market entryprescription medication

Related Companies

$ZEAL $OPTN

Read the original article

Published by PR Newswire Pharma on September 8, 2026 4:16 PM

Read Original